Home » Authors » Mark McCarty

Articles by Mark McCarty

Health Canada poised to roll out user fees for med-tech products

Aug. 17, 2007

By Mark McCarty

Congress to examine FDA’s handling of Cordis violations

Aug. 16, 2007

By Mark McCarty

Gebauer, artificial saliva maker, terminates in-house production

Aug. 15, 2007

By Mark McCarty

Bone density gets cost-effective analytical look in JAMA article

Aug. 13, 2007

By Mark McCarty

CMS to reexamine non-coverage policy for artificial heart sector

Aug. 9, 2007

By Mark McCarty

Washington roundup: Congress is again getting cold feet about CMS action on DRGs

Aug. 9, 2007

By Mark McCarty

Congress is again getting cold feet about CMS action on DRGs

Aug. 8, 2007

By Mark McCarty

Congress drops FDA ball until September: layoffs could ensue

Aug. 6, 2007

By Mark McCarty

House CHIP bill hits Medicare plans, skilled nursing facilities

Aug. 3, 2007

By Mark McCarty

Failure of California RHIO offers instructive how-not-to study

Aug. 2, 2007

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...